Cargando…

SARS-CoV-2 serological cross-reactivity with autoantibodies

Detalles Bibliográficos
Autor principal:	Choy, Kay Weng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758714/ https://www.ncbi.nlm.nih.gov/pubmed/33392517 http://dx.doi.org/10.1016/S2665-9913(20)30358-1

Ejemplares similares

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Serological assays for delayed SARS-CoV-2 case identification
por: Choy, Kay Weng
Publicado: (2020)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Association of SARS-CoV-2 renal tropism with acute kidney injury
por: Choy, Kay Weng
Publicado: (2020)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

Challenges in interpreting SARS-CoV-2 serological results in African countries
por: Nkuba Ndaye, Antoine, et al.
Publicado: (2021)

Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?
por: Dudreuilh, Caroline, et al.
Publicado: (2020)

Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
por: Fraley, Elizabeth, et al.
Publicado: (2021)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’
por: De Vriese, An S., et al.
Publicado: (2020)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
por: Perez-Saez, Javier, et al.
Publicado: (2021)

Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays
por: Tian, Ying, et al.
Publicado: (2020)

Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2021)

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses
por: Hicks, Jennifer, et al.
Publicado: (2020)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses
por: Ma, Zhongren, et al.
Publicado: (2020)

Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II
por: Briquez, Priscilla S., et al.
Publicado: (2021)

Arthritis after SARS-CoV-2 infection: reactive arthritis or virally mediated arthritis?
por: Baimukhamedov, Chokan, et al.
Publicado: (2022)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

The proximal origin of SARS-CoV-2
por: Andersen, Kristian G., et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in Spain
por: Hoffmann, Christian, et al.
Publicado: (2020)

Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin
por: McAlpine, Lindsay S., et al.
Publicado: (2023)

Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids()
por: Varona Pérez, J., et al.
Publicado: (2020)

Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
por: Cao, Yanlin, et al.
Publicado: (2023)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2t5vu13qete3fmq4kaj70bujli